PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.\', \'Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, the Netherlands.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.\', \'Tissue Typing and Immunogenetics Unit, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel.\', \'Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.\', \'The de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.\', \'Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.\', \'Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: yardena.samuels@weizmann.ac.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(21)00681-110.1016/j.celrep.2021.109305
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 34166618
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
?:title
  • Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34166618>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34166618>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all